D. Medical in talks for potential acquisition

Tweet D. Medical Industries (NASDAQ, TASE:DMED) is negotiating a potential acquisition transaction with an unaffiliated third party in the business of medical devices for diabetes. Under the proposed transaction, D. Medical would purchase 100% of the issued and outstanding share capital of the target company from its current shareholders, in exchange for a combination of [...]

D. Medical signs additional U.S. distribution agreement

Tweet D. Medical Industries (NASADQ, TASE:DMED) has signed a non-exclusive agreement with an undisclosed party for the distribution of its Spring Universal Infusion Sets in the U.S. The agreement has an initial term of two years, and then will be automatically renewed for one-year periods, unless terminated by the parties. In addition, each party may [...]

D. Medical gets first payment under worldwide OEM pact

Tweet D. Medical Industries (NASDAQ, TASE:DMED) has received the first payment under an original equipment manufacturer agreement with Twobiens Ltd., a leading South Korea-based supplier of diabetes treatment and drug delivery products, for the worldwide distribution of its Spring Universal Detach Detect Infusion Sets under Twobiens’ private label. The first payment from Twobiens represents one-third [...]

D. Medical in worldwide OEM pact with Twobiens

Tweet D. Medical Industries (NASDAQ, TASE:DMED) has entered into an original equipment manufacturer agreement with Twobiens, a leading South Korean supplier of diabetes treatment and drug delivery products, for the worldwide distribution of its Spring Universal Detach Detect Infusion Sets under Twobiens’ private label. The three-year agreement contains annual sales targets and minimum order quantities [...]

D. Medical in strategic reorganization

Tweet D. Medical Industries (NASDAQ, TASE:DMED) has initiated a strategic restructuring designed to focus its business on maximizing and realizing the value of the company’s novel technology and intellectual property by licensing and/or selling the technology, or part of it, to third parties. At the same time, D. Medical said it will continue to pursue [...]

D. Medical CEO interviewed on Bloomberg TV

Tweet Efri Argaman, CEO of D. Medical Industries (NASDAQ, TASE:DMED), was interviewed today by Sara Eisen on Bloomberg Television’s “InsideTrack.” Mr. Argaman discussed a host of topics, ranging from the state of the U.S. diabetes market, regulatory oversight and D. Medical’s sales strategy in the U.S. Instead of setting up a direct and costly U.S. [...]

D. Medical expands U.S. distribution of infusion sets

Tweet D. Medical Industries (NASDAQ, TASE:DMED) has signed a non-exclusive agreement with Better Living Now, expanding the distribution of its Spring Universal Infusion Sets in the U.S. “The signing of this, our fourth distribution agreement in the U.S., is a key milestone achievement for our company,” D. Medical CEO Efri Argaman said in a statement, [...]

D. Medical gets CE Mark for insulin pump

Tweet D. Medical Industries (NASDAQ, TASE:DMED)  has received a CE Mark approval for its Spring Zone Insulin Delivery System, which replaces the first generation Spring ADI insulin pump. The proprietary Intellispring technology at the heart of the Spring Zone insulin pump results in performance advantages such as superior blockage and detachment detection, environmental (pressure and [...]

D. Medical expands U.S. distribution for infusion sets

Tweet D. Medical Industries (NASDAQ, TASE:DMED) has signed a non-exclusive distribution agreement with Agile Edge Technologies for the distribution of its Spring Universal Infusion Sets in the U.S. “This marks our third non-exclusive distribution agreement and provides us with important new access to the governmental sector,” D. Medical CEO Efri Argaman said in a statement. [...]

D. Medical issued U.S. patent

Tweet D. Medical Industries (NASDAQ, TASE:DMED) has been granted a U.S. patent, entitled “Devices For Continuous Measurement of Glucose in Body Fluid,” which protects innovative technology that allows for the combination of a minimally invasive continuous glucose monitor and an insulin pump on the same “patch.” Among other features, the technology enables the use of [...]

Next Page »